News Feed Opinion Blog Posts Career Updates Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
What Challenges Will Oncologists Face in 2025? – ASCO
Nathan A. Pennell and John Sweetenham
Dec 13, 2024, 18:57

What Challenges Will Oncologists Face in 2025? – ASCO

ASCO shared on X:

“Nathan A. Pennell of Cleveland Clinic and Dr. John Sweetenham discuss the top challenges oncologists will face in 2025 + technology’s potential to truly improve patient outcomes on the latest episode of the ASCO Daily News.”

Full Podcast on ASCO Daily News.

ASCO cancer Cleveland Clinic John Sweetenham Nathan A.Pennell OncoDaily Oncology
Special Coverage
Voices
Aug 24, 2025, 19:14
Aakash Desai Highlighted JTO Study on MTAP as Biomarker in NSCLC
Voices
Aug 24, 2025, 18:48
Douglas Flora Highlights the Power of Early Cancer Detection and the Need for Policy Change
Voices
Aug 24, 2025, 18:41
Launching a New eBook for Patient Empowerment - Society for Integrative Oncology
Career Updates
Aug 24, 2025, 18:34
Conquer Cancer Welcomes Darby Joyce Seftor to the Team
Voices
Aug 24, 2025, 18:06
Jia Liu: Remembering Gary Mar’s Legacy of Advocacy in Head and Neck Cancer
Voices
Aug 24, 2025, 18:04
Chris McKee: MD Anderson Hosts Regional Training on Breast Imaging for Latin American Colleagues
Insight
Aug 24, 2025, 17:46
A New Viewpoint on the Role of Common Sense Oncology in the Western Pacific - CSO
Voices
Aug 24, 2025, 17:38
Meet the Stories Behind WeAllLiveIt - Childhood Cancer International
Voices
Aug 24, 2025, 17:28
Redressing the Manneken Pis as a Paediatric Oncologist for the Gold September - SIOP Europe
Blog Posts
Aug 24, 2025, 17:21
Norman Ng: Ensuring that Lung Cancer Patients Are Given a Fighting Chance
Voices
Aug 24, 2025, 17:13
Juan W Valle: Digital and Biological Twins in Cholangiocarcinoma
Science
Aug 24, 2025, 17:03
Saheli Sadanand Highlights a Study on CAR T Cells Showing Promise in High-Risk Neuroblastoma